Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014630 |
| CAS No | NA |
| Mol.F. | C8H10ClN3O2 |
| Mol.Wt. | 215.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014631 |
| CAS No | NA |
| Mol.F. | C22H17N7O |
| Mol.Wt. | 395.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014632 |
| CAS No | NA |
| Mol.F. | C22H17N7O |
| Mol.Wt. | 395.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014633 |
| CAS No | NA |
| Mol.F. | C22H16N8O2 |
| Mol.Wt. | 424.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014634 |
| CAS No | NA |
| Mol.F. | C20H22N8O7 : Ca |
| Mol.Wt. | 486.4 : 40.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014635 |
| CAS No | NA |
| Mol.F. | C20H22N8O7 : Ca |
| Mol.Wt. | 486.4 : 40.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014636 |
| CAS No | NA |
| Mol.F. | C20H21N9O8 : Ca |
| Mol.Wt. | 515.4 : 40.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014637 |
| CAS No | NA |
| Mol.F. | C20H20N6O7 |
| Mol.Wt. | 456.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014638 |
| CAS No | NA |
| Mol.F. | C20H19N7O8 |
| Mol.Wt. | 485.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014639 |
| CAS No | NA |
| Mol.F. | C20H20N6O7 |
| Mol.Wt. | 456.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014640 |
| CAS No | NA |
| Mol.F. | C19H19F3N4O4 |
| Mol.Wt. | 424.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014641 |
| CAS No | NA |
| Mol.F. | C16H17N5OS |
| Mol.Wt. | 327.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014642 |
| CAS No | NA |
| Mol.F. | C9H12N2O3 |
| Mol.Wt. | 196.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014643 |
| CAS No | NA |
| Mol.F. | C13H13N3O2 |
| Mol.Wt. | 243.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014644 |
| CAS No | NA |
| Mol.F. | C17H18N4O2 |
| Mol.Wt. | 310.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014645 |
| CAS No | NA |
| Mol.F. | C29H29N7O7 |
| Mol.Wt. | 587.6 |
| INV STATUS | CUSTOM SYNTHESIS |